ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
DSM has agreed to evaluate a cell-free biomanufacturing process developed by Debut Biotechnology, a start-up formed in 2019 with technology licensed from the University of California, Irvine. Debut says its enzymatic production process overcomes the limitations of both petroleum-based chemical synthesis and cell-based fermentation. DSM says it will test the process on specialty food and nutritional ingredients.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X